Funded Tech Companies
Zura Bio
Zura Bio, operating out of San--Diego, raised money from Great Point Partners, Suvretta Capital Management and Deep Track Capital.
Company Overview
Company Name
Zura Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4225 Executive Square 600
San--Diego, CA 92037
USA
San--Diego, CA 92037
USA
Phone
Website
Email Address
Company Background Information
Overview
Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and Torudokimab. ZB-168 is an anti IL7R a inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/6/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Amit Munshi
Chief Executive Officer
Someit Sidhu
Chief Financial Officer
Verender Badial
Chief Medical Officer
Chris Cabell
Chief Scientific Officer
Michael Howell
Chief Technical Officer
Gary Whale
Company Investors
- Great Point Partners
- Suvretta Capital Management
- Deep Track Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs